Vicapsys Life Sciences, Inc.
OTC:VICP
2 (USD) • At close November 9, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.785 | 6.802 |
| Cost of Revenue
| 0 | 0.031 | 0.031 | 0.031 | 0.031 | 0.127 | 0.179 | 7.24 | 6.943 |
| Gross Profit
| 0 | -0.031 | -0.031 | -0.031 | -0.031 | -0.127 | -0.179 | 0.545 | -0.141 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.07 | -0.021 |
| Reseach & Development Expenses
| 0.015 | 0.013 | 0.018 | 0.102 | 0.099 | 0.099 | 0.233 | 0 | 0 |
| General & Administrative Expenses
| 0.769 | 0.631 | 0.319 | 0.664 | 0.935 | 0.583 | 0.818 | 1.796 | 1.944 |
| Selling & Marketing Expenses
| 0 | 0.122 | 0 | 0 | 0 | 0.476 | 2.005 | 0.055 | 0.179 |
| SG&A
| 0.769 | 0.631 | 0.319 | 0.664 | 0.935 | 1.059 | 2.822 | 1.85 | 2.123 |
| Other Expenses
| 0.263 | 0.463 | 0.092 | 286.327 | 0 | 0 | 0 | 0.048 | 0.095 |
| Operating Expenses
| 1.047 | 0.645 | 0.337 | 0.766 | 1.034 | 1.158 | 3.055 | 1.898 | 2.219 |
| Operating Income
| -1.047 | -0.985 | -0.337 | -0.766 | -1.034 | -1.285 | -3.234 | -1.354 | -2.359 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.174 | -0.347 |
| Total Other Income Expenses Net
| -0.135 | -0.34 | 0.1 | -0 | 0 | 0 | 0 | 0.004 | -0.012 |
| Income Before Tax
| -1.182 | -0.985 | -0.237 | -0.766 | -1.034 | -1.285 | -3.234 | -1.67 | -2.438 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.215 | -0.358 |
| Income Tax Expense
| 0 | 0.68 | -0.1 | -0 | 0.376 | 0.918 | 0 | -0.004 | 0.012 |
| Net Income
| -1.182 | -1.665 | -0.137 | -0.766 | -1.41 | -2.202 | -3.234 | -1.67 | -2.438 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.215 | -0.358 |
| EPS
| -0.034 | -0.055 | -0.008 | -0.044 | -0.12 | -0.23 | -0.54 | -4.82 | -7.16 |
| EPS Diluted
| -0.034 | -0.055 | -0.008 | -0.044 | -0.12 | -0.23 | -0.54 | -4.82 | -7.16 |
| EBITDA
| -1.047 | -0.273 | -0.406 | -0.734 | -1.003 | -1.158 | -3.055 | -1.23 | -2.23 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.158 | -0.328 |